Technical Analysis for ADTX - ADiTx Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.10 | 2.94% | 0.06 |
ADTX closed up 2.94 percent on Wednesday, May 8, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 2.94% | |
| New 52 Week Closing Low | Bearish | 2.94% | |
| New 52 Week Low | Weakness | 2.94% | |
| Stochastic Reached Oversold | Weakness | 2.94% | |
| Wide Bands | Range Expansion | 2.94% |
| Alert | Time |
|---|---|
| Possible NR7 | about 12 hours ago |
| Possible Inside Day | about 12 hours ago |
| Up 3% | about 15 hours ago |
| Up 2% | about 16 hours ago |
| Up 1% | about 16 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/29/2023
Aditx Therapeutics, Inc., is developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. The immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. The immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Immune System Immunotherapy Autoimmune Disease Autoimmunity Organs Allergies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Immune System Immunotherapy Autoimmune Disease Autoimmunity Organs Allergies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 68.08 |
| 52 Week Low | 1.95 |
| Average Volume | 432,704 |
| 200-Day Moving Average | 7.84 |
| 50-Day Moving Average | 2.98 |
| 20-Day Moving Average | 2.42 |
| 10-Day Moving Average | 2.32 |
| Average True Range | 0.25 |
| RSI (14) | 33.33 |
| ADX | 18.99 |
| +DI | 20.33 |
| -DI | 24.77 |
| Chandelier Exit (Long, 3 ATRs) | 2.68 |
| Chandelier Exit (Short, 3 ATRs) | 2.69 |
| Upper Bollinger Bands | 2.94 |
| Lower Bollinger Band | 1.90 |
| Percent B (%b) | 0.19 |
| BandWidth | 43.10 |
| MACD Line | -0.24 |
| MACD Signal Line | -0.24 |
| MACD Histogram | -0.0031 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.21 | ||||
| Resistance 3 (R3) | 2.20 | 2.16 | 2.19 | ||
| Resistance 2 (R2) | 2.16 | 2.13 | 2.16 | 2.18 | |
| Resistance 1 (R1) | 2.13 | 2.12 | 2.15 | 2.14 | 2.18 |
| Pivot Point | 2.09 | 2.09 | 2.10 | 2.09 | 2.09 |
| Support 1 (S1) | 2.06 | 2.06 | 2.08 | 2.07 | 2.02 |
| Support 2 (S2) | 2.02 | 2.05 | 2.02 | 2.02 | |
| Support 3 (S3) | 1.99 | 2.02 | 2.01 | ||
| Support 4 (S4) | 2.00 |
